A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging

doi:10.1021/acsami.7b04038

SIC OpenIR

	A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging
	Janoniene, Agne 1,2; Liu, Zehua 2; Baranauskiene, Lina 1; Mäkilä, Ermei 3; Ma, Ming 4; Salonen, Jarno 3; Hirvonen, Jouni 2; Zhang, Hongbo 2,5; Petrikaite, Vilma 1,6; Santos, Hélder A.2
	2017
发表期刊	ACS Applied Materials and Interfaces
ISSN	19448244
卷号	9 期号:16 页码:13976-13987
摘要	Hypoxia occurs in most solid tumors, and it has been shown to be an independent prognostic indicator of a poor clinical outcome for patients with various cancers. Therefore, constructing a nanosystem specifically targeting cancer cells under hypoxia conditions is a promising approach for cancer therapy. Herein, we develop a porous silicon (PSi)-based nanosystem for targeted cancer therapy. VD11-4-2, a novel inhibitor for carbonic anhydrase IX (CA IX), is anchored on PSi particles (VD-PSi). As CA IX is mainly expressed on the cancer cell membrane under hypoxia condition, this nanocomplex inherits a strong affinity toward hypoxic human breast adenocarcinoma (MCF-7) cells; thus, a better killing efficiency for the hypoxia-induced drug resistance cancer cell is observed. Furthermore, the release of doxorubicin (DOX) from VD-PSi showed pH dependence, which is possibly due to the hydrogen-bonding interaction between DOX and VD11-4-2. The fluorescence resonance energy transfer effect between DOX and VD11-4-2 is observed and applied for monitoring the DOX release intracellularly. Protein inhibition and binding assays showed that VD-PSi binds and inhibits CA IX. Overall, we developed a novel nanosystem inheriting several advantageous properties, which has great potential for targeted treatment of cancer cells under hypoxic conditions. © 2017 American Chemical Society.
DOI	10.1021/acsami.7b04038
EI入藏号	20171803613905
EI主题词	Carbonic anhydrase
EI分类号	461.2 Biological Materials and Tissue Engineering - 461.6 Medicine and Pharmacology - 549.3 Nonferrous Metals and Alloys excluding Alkali and Alkaline Earth Metals - 761 Nanotechnology - 801.2 Biochemistry - 801.4 Physical Chemistry - 933 Solid State Physics
引用统计
文献类型	期刊论文
条目标识符	http://ir.sic.ac.cn/handle/331005/25943
专题	中国科学院上海硅酸盐研究所
作者单位	1.Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Vilnius University, Vilnius; LT-10257, Lithuania; 2.Division of Pharmaceutical Chemistry and Technology, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki; FI-00014, Finland; 3.Laboratory of Industrial Physics, Department of Physics, University of Turku, Turku; FI-20014, Finland; 4.Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai; 200050, China; 5.Department of Pharmaceutical Science, Åbo Akademi University, Turku; FI-20520, Finland; 6.Department of Drug Chemistry, Faculty of Pharmacy, Lithuanian University of Health Sciences, Kaunas; LT-44307, Lithuania
推荐引用方式 GB/T 7714	Janoniene, Agne,Liu, Zehua,Baranauskiene, Lina,et al. A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging[J]. ACS Applied Materials and Interfaces,2017,9(16):13976-13987.
APA	Janoniene, Agne.,Liu, Zehua.,Baranauskiene, Lina.,Mäkilä, Ermei.,Ma, Ming.,...&Santos, Hélder A..(2017).A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging.ACS Applied Materials and Interfaces,9(16),13976-13987.
MLA	Janoniene, Agne,et al."A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging".ACS Applied Materials and Interfaces 9.16(2017):13976-13987.